↓ Skip to main content

Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial

Overview of attention for article published in BMC Cancer, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
11 X users
patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
184 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Published in
BMC Cancer, August 2012
DOI 10.1186/1471-2407-12-355
Pubmed ID
Authors

Zohreh Ghoreishi, Ali Esfahani, Abolghasem Djazayeri, Mahmoud Djalali, Banafsheh Golestan, Hormoz Ayromlou, Shahriar Hashemzade, Mohammad Asghari Jafarabadi, Vahid Montazeri, Seyed Ali Keshavarz, Masoud Darabi

Abstract

Axonal sensory peripheral neuropathy is the major dose-limiting side effect of paclitaxel.Omega-3 fatty acids have beneficial effects on neurological disorders from their effects on neurons cells and inhibition of the formation of proinflammatory cytokines involved in peripheral neuropathy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Canada 2 1%
India 1 <1%
Unknown 179 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 16%
Student > Master 21 11%
Student > Bachelor 19 10%
Student > Ph. D. Student 15 8%
Student > Postgraduate 15 8%
Other 39 21%
Unknown 45 24%
Readers by discipline Count As %
Medicine and Dentistry 54 29%
Agricultural and Biological Sciences 20 11%
Nursing and Health Professions 19 10%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Neuroscience 9 5%
Other 18 10%
Unknown 55 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2023.
All research outputs
#2,632,099
of 24,195,945 outputs
Outputs from BMC Cancer
#506
of 8,597 outputs
Outputs of similar age
#17,107
of 170,176 outputs
Outputs of similar age from BMC Cancer
#9
of 91 outputs
Altmetric has tracked 24,195,945 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,597 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.